May 12, 2026 ยท GRPN ยท Gojo

GRPN: Buyback + Squeeze + AI Turnaround Wildcard

Groupon at $17, 53% short interest, $245M buyback authorization, and a hidden SumUp stake. Three distinct setups stacked on one ticker.

The Snapshot

  • Price: $17.42 (close May 12, 2026)
  • Market Cap: ~$550โ€“590M
  • Shares Outstanding: ~38M (down from 40.7M Q4 2025 โ€” already ~6% reduction in one quarter)
  • Cash: $225.5M
  • Short Interest: 53.17% of float, 7.59 days to cover
  • 2026 Revenue Guide: $513โ€“523M (+4% YoY)
  • 2026 EBITDA Guide: $70โ€“75M
  • 2026 FCF Guide: โ‰ฅ$60M

Why This Is Interesting

This isn't a clean fundamental story โ€” it's a structural setup. Three things are running at the same time, and that's the edge.

1. The Buyback Is Aggressive and Real

  • Q1 2026: $21.3M deployed, 2.8M shares repurchased
  • April 2026: additional 859,860 shares for $10.1M
  • $245M remaining on the authorization โ€” that's ~44% of the entire market cap

Most "buyback programs" are theater. This one isn't. Share count dropped ~6% in one quarter. If management keeps the pace, they could shrink the float meaningfully before year-end. That alone tightens the short side.

2. Short Interest Is at Squeeze Levels

53% of float short. 7.59 days to cover. That's the kind of number where any positive surprise โ€” an EBITDA beat in Q2, a SumUp IPO leak, an AI traction headline โ€” can ignite mechanical covering. The shorts aren't wrong about the business being broken. They might be wrong about the timing.

3. The SumUp Hidden Asset

Groupon owns a 2.4% stake in SumUp, a European payments company. At a $22.5B SumUp valuation (last cited), that stake is ~$500M โ€” close to Groupon's entire current market cap. SumUp has been circling an IPO for years. If it lists, Groupon either monetizes or marks it up. This is a binary catalyst sitting off the balance sheet.

4. The AI Pivot

CEO Dusan Senkypl is rebuilding Groupon as "AI-native":

  • AI voice agents for outbound merchant outreach โ€” goal: majority of new merchant meetings booked by AI by end of 2026
  • Groupon IQ AI deal-creation platform in production
  • 5% headcount cut in Q1, evaluating 15% global cut in Q2

Operating leverage on a flat revenue base. If billings stabilize and headcount drops 20% net, the EBITDA line walks up regardless of the top line.

The Q1 Print โ€” Why It Doesn't Kill the Thesis

  • Revenue $117M (flat YoY, in guidance)
  • Billings $383M (-1%, slightly below guide)
  • EPS -$0.32 vs -$0.02 expected โ€” ugly miss
  • Adj EBITDA $12.8M (below guide range)
  • Active customers +5% โ€” first meaningful uptick in years

The market reaction: stock had one of its best days in a year. That's the tell. Bad numbers, good price action = exhaustion + positioning. Bears already priced this; bulls saw the active customer growth and the buyback.

The Risk Stack

  • Turnaround #6: Groupon has been "turning around" since 2015. Pattern recognition says fade it.
  • Cash burn: $70M cash decline in one quarter (debt repayment + buyback). Burn pace matters if billings don't stabilize.
  • Convertible debt: $244M new notes at 4.875% due 2030 โ€” dilution potential at strike, real interest cost now.
  • AI narrative is unproven: "AI voice agents" is currently a slide, not a P&L line. If the merchant pipeline doesn't grow, the whole thesis collapses.
  • SumUp valuation: the $22.5B mark is aspirational. A real IPO could come in lower, or not come at all.

The Trade

  • Setup: Asymmetric long. Buyback + short squeeze fuel + binary SumUp catalyst, with operational turnaround as the slower-burn driver.
  • Risk: $13 (April low / pre-buyback zone). Below that, the turnaround narrative breaks.
  • Size: Speculative sleeve. This is not a core position โ€” it's a 1โ€“3% portfolio bet on multiple paths working.
  • Invalidation: Q2 prints with billings declining YoY, or buyback pace materially slowing.
  • Target: $25โ€“30 on Q2 beat + buyback continuation. $35+ on any SumUp liquidity event headline. Squeeze target uncapped if cover starts.

The Verdict

GRPN is not a quality stock. It's a structural setup. The fundamentals don't justify a buy on their own โ€” flat revenue, ugly EPS miss, multi-year turnaround track record. But the shape of the situation is rare: a company aggressively buying back ~44% of its market cap while 53% of the float is short, sitting on a potentially $500M off-balance-sheet asset, with a credible operational pivot.

You don't size this like a thesis trade. You size it like a free lottery ticket with three independent payoff paths. Asymmetric or skip โ€” no middle ground.